LHL. W. Ernest van Heurn

L. W. Ernest van Heurn

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


L. W. Ernest van Heurn has a total of 139 co-authors. Here are the top co-authors by number of shared publications:

  • Joep. P. M. Derikx

    Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Department of Pediatric Surgery, Amsterdam Reproduction and Development Research Institute, Amsterdam, the Netherlands

    11 shared publications
  • Ramon R. Gorter

    Department of Paediatric Surgery, Emma Children’s Hospital, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands

    9 shared publications
  • Roel Bakx

    Department of Paediatric Surgery, Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam & Vrije Universiteit Amsterdam, Amsterdam, The Netherlands

    5 shared publications
  • Adinda G. H. Pijpers

    Department of Pediatric Surgery, Emma Children's Hospital, Amsterdam UMC, Location University of Amsterdam, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, 1105 AZ, Amsterdam, the Netherlands; Amsterdam Reproduction & Development Research Institute, 1105 AZ, Amsterdam, the Netherlands

    3 shared publications
  • Bjorn Winkens

    Department of Methodology and Statistics, Maastricht University Medical Center+, Debyelaan 25, 6229 HX Maastricht, The Netherlands

    3 shared publications
  • Daniëlle Roorda

    Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Department of Pediatric Surgery, Amsterdam Reproduction and Development Research Institute, Amsterdam, the Netherlands; Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Department of Pediatrics, Emma Children's Hospital Amsterdam UMC Follow Me program & Emma Neuroscience Group, Amsterdam Reproduction and Development Research Institute, Amsterdam, the Netherlands

    3 shared publications

Latest Publications

  • Open Access

    Malignant transformation of sacrococcygeal teratoma versus presacral teratoma in Currarino syndrome: Results of ‘The SCT-study’

    by Lieke J van Heurn, Joep P M Derikx, Nigel J Hall, Amr Abdelhamid AbouZeid, Simone de Campos Vieira Abib, Lohfa B Chirdan, Shigehisa Fumino, Seong C Kim, Oliver Muensterer, Maricarmen Olivos, et al.

  • Open Access

    Standardized prospective multidisciplinary follow-up of patients with surgical congenital malformations: A model for continuous data driven improvement of health care

    by S.P. van Streun, D. Roorda, A.F.W. van der Steeg, R.R. Gorter, J.P.M. Derikx, L.W.E. van Heurn, J. Oosterlaan

  • Open Access

    Assessing Hepatic Steatosis Following Weight Loss in Adolescents with Severe Obesity: A Randomized Controlled Trial

    by Ali Talib, Fien De Boom, Yvonne Roebroek, Givan Florian Paulus, Ger Koek, Simon Robben, Bjorn Winkens, Nicole Bouvy, Ernst van Heurn

    Background/Objectives: To assess whether laparoscopic adjustable gastric banding (LAGB) and combined lifestyle intervention (CLI) reduce hepatic steatosis more effectively than CLI alone in adolescents with severe obesity. Methods: Adolescents aged 14–16 with a BMI ≥ 40 kg/m2 (or ≥35 kg/m2 with comorbidity) were randomized to receive LAGB + combined lifestyle intervention (CLI, n = 30) or CLI alone (n = 30). Hepatic fat was assessed at baseline and one year via ultrasound-based Hepatorenal Index (HRI), liver span, and ALAT levels. Results: Of 59 participants (mean age 15.7, 80% female, BMI 44.3 kg/m2), 58.9% had steatosis at baseline (HRI ≥ 1.40). After one year, BMI decreased by 5.6 kg/m2 in the LAGB group but remained stable in controls. Steatosis resolution (HRI < 1.05) occurred in 21.4% of LAGB versus 4.4% of CLI patients (p = 0.078). Liver span declined by 1.09 cm post-LAGB (95% CI −2.05 to −0.13) and correlated with HRI improvement. ALAT levels were unchanged. Conclusions: LAGB led to greater reductions in hepatic fat and size than lifestyle changes alone. Though steatosis resolution was not statistically significant, findings suggest bariatric surgery may be a promising strategy for mitigating early hepatic changes in severe adolescent obesity. What is already known: Severe obesity in adolescents is frequently accompanied by hepatic steatosis, which can progress to metabolic dysfunction–associated steatotic liver disease (MASLD). Bariatric procedures—such as laparoscopic adjustable gastric banding (LAGB)—are proven to induce substantial weight loss and improve obesity-related comorbidities in youth. What this study adds: This is the first randomized controlled trial to evaluate the effect of LAGB on hepatic steatosis specifically in adolescents. At one year, 21.4% of LAGB-treated patients no longer met the sensitive HRI cut-off for steatosis (<1.05) versus 4.4% of controls. Moderate weight loss after LAGB corresponded with significant improvements in the Hepatorenal Index and liver span, suggesting a reduction in hepatic fat content.


  • Open Access

    Time Heals: The Impact of Waiting Times on Pediatric Patients’ Decisions to Decline Pectus Surgery

    by Hendrik van Braak, Sjoerd A. de Beer, Matthijs W.N. Oomen, Sander Zwaveling, Joep P.M. Derikx, L.W. Ernest van Heurn, Justin R. de Jong

  • Open Access

    The Effect of Bariatric Surgery on Quality of Life and Depression

    by Fien de Boom, Chantal Nederkoorn, Yvonne G.M. Roebroek, Givan F. Paulus, Bjorn Winkens, Nicole D. Bouvy, Ernest van Heurn


  • Open Access

    Improving Quality of Life With Dynamic Compression Bracing in Patients With Pectus Carinatum

    by Hendrik van Braak, Sjoerd A. de Beer, Jos W.R. Twisk, Sander Zwaveling, Matthijs W.N. Oomen, Justin R. de Jong, L.W. Ernest van Heurn


  • Open Access

    Malignant transformation and tumour recurrence in sacrococcygeal teratoma: a global, retrospective cohort study

    by Lieke J. van Heurn, Joep P.M. Derikx, Nigel Hall, Jennifer H. Aldrink, Maria M. Bailez, Lohfa B. Chirdan, Shigehisa Fumino, Afua Hesse, Tuktu Soyer, Shawn StPeter, et al.

    Introduction: Sacrococcygeal teratoma (SCT) is a rare congenital tumour. The risk of malignancy and recurrence is not well defined. Previous studies are small and report differing conclusions about the timing of surgery and the duration of follow-up. The authors studied the risk of malignant transformation and SCT recurrence after surgery to address these gaps. Methods: This was a global retrospective cohort study. Data of consecutive SCT patients was obtained from 145 institutes in 62 countries. Malignant transformation, defined as malignancy at initial resection, malignant recurrence or death due to malignancy, and its risk factors were analysed. Results: Of the 3612 included patients, 3407 entered analysis. The risk of malignant transformation of the initial tumour was 3.3, 5.1, 10.1, and 32.9% at age 3 months, 6 months, 1 year, and 2 years, respectively. After 6 years, the censored risk of malignancy (64%) did not further increase. Recurrent SCT was diagnosed in 349 (10.2%) children with 126 (36.1%) malignant recurrences. Risk factors for recurrence were Altman type II [odds ratio (OR): 1.6, 95% confidence interval (CI): 1.2–2.2], Altman type III (OR: 1.6, 95% CI: 1.2–2.3), initial immature histology (OR: 1.9, 95% CI: 1.4–2.6), and initial malignant histology (OR: 4.0, 95% CI: 2.9–5.4). Conclusion: The risk of malignancy at initial resection in SCT increases with age reaching a plateau at 6 years of age. Recurrence after resection occurred in 10% of patients and 36% of these were malignant at that time. Altman type II or type III, and immature or malignant histology were associated with recurrence. Level of evidence: Level III.


  • Open Access

    Non-Invasive Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease in Adolescents with Severe Obesity; Patient Characteristics and Association with Leptin—A Cross-Sectional Overview of Baseline Data from a RCT

    by Fien de Boom, Ali Talib, Yvonne G. M. Roebroek, Givan F. Paulus, Ger H. Koek, Simon G. F. Robben, Bjorn Winkens, Nicole D. Bouvy, L. W. Ernest van Heurn

    Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease in adolescents with obesity. Nonetheless, the guidelines for screening and managing this disease are contradictory. The purpose of this study is to non-invasively assess the prevalence, patient characteristics, and potential associated factors of MASLD in this demographic. Methods: This study used baseline data from an RCT in adolescents eligible for bariatric surgery. MASLD was determined by measuring the hepatorenal index (HRI) with ultrasonography, blood liver tests, and the fatty liver index (FLI). Results: A total of 56 adolescents enrolled in the analyses; the majority were female n = 44 (79%); the mean age was 15.75 (±1.01) years; the average body mass index (BMI) was 44.08 (±5.16) kg/m2. In 35 (62.5%) of the patients, the HRI was abnormal. This group had a higher waist/hip ratio, elevated liver biochemistry, and significantly lower leptin levels (mean difference = −46.35, 95% CI −76.72, −15.99) compared to the group with a normal HRI. In 32 (55.2%) of the patients, ALT levels were elevated and the FLI was abnormal in all (100%) participants. Linear regression analysis indicated associations between the HRI and typical anthropometric and metabolic measurements; and an inverse association between HRI and leptin B = −0.003 (95% CI −0.005, −0.00), independently of sex- and age-adjusted BMI. Conclusions: MASLD is highly prevalent in adolescents with severe obesity. However, the prevalence strongly depends on which tool is used, namely the HRI (62.5%), alanine transaminase levels (55.2%), and FLI (100%). Our findings suggest that leptin may be a valuable biomarker in supporting the diagnosis of MASLD.


  • Open Access

    Identifying Preoperative Clinical Characteristics of Unexpected Gastrointestinal Perforation in Infants—A Retrospective Cohort Study

    by Adinda G. H. Pijpers, Ramon R. Gorter, Laurens D. Eeftinck Schattenkerk, Joost van Schuppen, Chris H. P. van Den Akker, Sylvie Vanhamel, Ernest L. W. van Heurn, Gijsbert D. Musters, Joep P. M. Derikx

    Background: Infants presenting with unexpected pneumoperitoneum upon abdominal X-ray, indicating a gastrointestinal perforation (GIP), have a surgical emergency with potential morbidity and mortality. Preoperative determination of the location of perforation is challenging but will aid the surgeon in optimizing the surgical strategy, as colon perforations are more challenging than small bowel perforations. Therefore, the aim of this study is to provide an overview of preoperative patient characteristics, determine the differences between the small bowel and colon, and determine underlying causes in a cohort of infants with unexpected GIP. Methods: All infants (age ≤ 6 months) who presented at our center with unexpected pneumoperitoneum (no signs of pneumatosis before) undergoing surgery between 1996 and 2024 were retrospectively included. The differences between the location of perforation were analyzed using chi-squared and t-tests. Bonferroni correction was used to adjust for multiple tests. Results: In total, 51 infants presented with unexpected pneumoperitoneum at our center, predominantly male (N = 36/51) and premature (N = 40/51). Among them, twenty-six had small bowel, twenty-two colon, and three stomach perforations. Prematurity (p = 0.001), birthweight < 1000 g (p = 0.001), respiratory support (p = 0.001), and lower median arterial pH levels (p = 0.001) were more present in patients with small bowel perforation compared with colon perforations. Pneumatosis intestinalis was more present in patients with colon perforation (p = 0.004). All patients with Hirschsprung disease and cystic fibrosis had colon perforation. The final diagnoses were mainly focal intestinal perforations (N = 27/51) and necrotizing enterocolitis (N = 9/51). Conclusions: Infants with unexpected GIP, birthweight < 1000 g, and prematurity have more risk for small bowel perforation. In case of colon perforation, additional screening (for Hirschsprung and cystic fibrosis) should be considered.


  • Open Access

    Trends in Simple and Complex Appendicitis in Children and the Potential Correlation to Common Viral Pathogens—A Retrospective Cohort Study between 2010 and 2019 in The Netherlands

    by Sarah-May M. L. The, Paul van Amstel, Sophie M. Noordzij, Roel Bakx, Taco. S. Bijlsma, Joep. P. M. Derikx, L. W. Ernest van Heurn, Martijn van der Kuip, Ramon R. Gorter

    The aim of this study was to evaluate the annual, seasonal and monthly trends in children with simple and complex appendicitis and their correlation to common viral pathogens in the Netherlands. A consecutive multicenter retrospective cohort study was performed between 2010 and 2019 including children (p < 0.001). An overall decline was demonstrated for both simple and complex appendicitis between 2010 and 2019. No seasonal variation was found for simple appendicitis. For complex appendicitis, the highest number of patients was found in spring, and lowest in summer (N = 372, spring 28.2 ± 5.1% versus summer 21.0 ± 5.8%, p = 0.011), but the variance was regarded as not relevant (p = 0.026) and simple appendicitis with Adenovirus NON 40.41 (R = 0.332, 95%CI 0.019–0.586, p = 0.039), but these correlations did not remain significant after a Bonferroni correction (p < 0.003). In conclusion, we found no relevant seasonal variation for simple or complex appendicitis, nor positive correlation with common viral pathogens.